Coston McIsaac & Partners
LLY icon

Coston McIsaac & Partners’s Eli Lilly LLY Stock Holding History

Coston McIsaac & Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$621K Buy
536
+6
+1% +$7.08K 0.13% 81
2026
Q2 		$636K Buy
530
+1
+0.2% +$1.02K 0.13% 83
2026
Q1 		$486K Hold
529
– – 0.11% 82
2025
Q4 		$568K Buy
529
+1
+0.2% +$956 0.13% 81
2025
Q3 		$403K Hold
528
– – 0.1% 93
2025
Q2 		$412K Buy
528
+12
+2% +$9.32K 0.11% 93
2025
Q1 		$426K Sell
516
-3
-0.6% -$2.5K 0.12% 84
2024
Q4 		$400K Buy
519
+2
+0.4% +$1.66K 0.12% 89
2024
Q3 		$458K Buy
517
+1
+0.2% +$899 0.13% 84
2024
Q2 		$467K Hold
516
– – 0.15% 75
2024
Q1 		$401K Buy
516
+1
+0.2% +$712 0.13% 84
2023
Q4 		$300K Hold
515
– – 0.1% 89
2023
Q3 		$276K Sell
515
-23
-4% -$11.9K 0.1% 86
2023
Q2 		$252K Hold
538
– – 0.09% 102
2023
Q1 		$184K Buy
538
+157
+41% +$53K 0.07% 113
2022
Q4 		$139K Hold
381
– – 0.05% 143
2022
Q3 		$123K Hold
381
– – 0.06% 136
2022
Q2 		$124K Buy
+381
New +$114K 0.07% 89

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Coston McIsaac & Partners's LLY Position: Q3 2026 in Review

Coston McIsaac & Partners increased its Eli Lilly (LLY) stake by 1.1% in Q3 2026, buying an estimated $7.08K and bringing the position to 536 shares worth $621K. The position accounts for 0.13% of the portfolio, ranked #81.

Coston McIsaac & Partners first reported a position in LLY in Q2 2022 and has held it in 18 quarters since. The position peaked at $636K in Q2 2026. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Coston McIsaac & Partners held 536 shares of Eli Lilly worth $621K as of Q3 2026.
  • Coston McIsaac & Partners bought 6 Eli Lilly shares in Q3 2026, an estimated $7.08K.
  • Eli Lilly made up 0.13% of Coston McIsaac & Partners's portfolio in Q3 2026, its #81 holding.
  • Coston McIsaac & Partners first reported a position in Eli Lilly in Q2 2022 and has held it in 18 quarters since.
  • Coston McIsaac & Partners's Eli Lilly position peaked at $636K in Q2 2026.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Coston McIsaac & Partners's 13F filing for Q3 2026, filed 6 Nov 2026.